ProfileGDS4718 / 222899_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 53% 51% 53% 55% 45% 46% 50% 54% 57% 51% 50% 45% 52% 46% 49% 51% 49% 54% 50% 62% 50% 53% 52% 49% 48% 54% 53% 46% 51% 51% 47% 51% 53% 51% 53% 51% 46% 53% 53% 56% 52% 46% 80% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6636453
GSM549102patient 115, normal, homogenized [OPG study]5.5931351
GSM549104patient 119, normal, homogenized [OPG study]5.6998453
GSM549108patient 138, normal, homogenized [OPG study]5.8445955
GSM549119patient 077, normal, homogenized [OPG study]5.2757845
GSM549133patient 032, cancer, homogenized [OPG study]5.2548446
GSM549139patient 042, cancer, homogenized [OPG study]5.4849850
GSM549099patient 107, normal, homogenized [OPG study]5.7280854
GSM549109patient 139, normal, homogenized [OPG study]5.926157
GSM549110patient 046, normal, homogenized [OPG study]5.5831151
GSM549114patient 063, normal, homogenized [OPG study]5.4683250
GSM549122patient 082, normal, homogenized [OPG study]5.2354945
GSM549134patient 033, cancer, homogenized [OPG study]5.6179852
GSM549136patient 036, cancer, homogenized [OPG study]5.2460246
GSM549140patient 044, cancer, homogenized [OPG study]5.4362749
GSM549111patient 047, normal, homogenized [OPG study]5.5340851
GSM549113patient 057, normal, homogenized [OPG study]5.3857949
GSM549132patient 031, cancer, homogenized [OPG study]5.7357454
GSM549137patient 038, cancer, homogenized [OPG study]5.5249750
GSM549142patient 047, cancer, homogenized [OPG study]6.3193462
GSM549100patient 110, normal, homogenized [OPG study]5.5400250
GSM549107patient 135, normal, homogenized [OPG study]5.6606853
GSM549115patient 068, normal, homogenized [OPG study]5.5626552
GSM549116patient 072, normal, homogenized [OPG study]5.4650149
GSM549120patient 078, normal, homogenized [OPG study]5.413248
GSM549131patient 030, cancer, homogenized [OPG study]5.6794554
GSM549118patient 074, normal, homogenized [OPG study]5.7127153
GSM549129patient 027, cancer, homogenized [OPG study]5.3312446
GSM549123patient 088, normal, homogenized [OPG study]5.5322551
GSM549124patient 006, cancer, homogenized [OPG study]5.574351
GSM549126patient 015, cancer, homogenized [OPG study]5.3102747
GSM549128patient 025, cancer, homogenized [OPG study]5.571751
GSM549103patient 117, normal, homogenized [OPG study]5.718853
GSM549117patient 073, normal, homogenized [OPG study]5.5263251
GSM549138patient 041, cancer, homogenized [OPG study]5.7127653
GSM549141patient 045, cancer, homogenized [OPG study]5.51751
GSM549130patient 028, cancer, homogenized [OPG study]5.2986646
GSM549101patient 111, normal, homogenized [OPG study]5.7086953
GSM549105patient 128, normal, homogenized [OPG study]5.6858353
GSM549106patient 134, normal, homogenized [OPG study]5.8528656
GSM549112patient 048, normal, homogenized [OPG study]5.6361152
GSM549125patient 011, cancer, homogenized [OPG study]5.3092846
GSM549127patient 024, cancer, homogenized [OPG study]7.9302780
GSM549135patient 035, cancer, homogenized [OPG study]5.5992652